Analyst Consensus
- Current Price
- 259.56 $
- Target (Low)
- 150.00 $
- Target (Mean)
- 200.57 $
- Target (High)
- 290.00 $
- Recommendation
- Buy
- Number of Analysts
- 28
Recommendation Distribution
Recommendation Distribution| Strong Buy | 5 |
|---|
| Buy | 13 |
|---|
| Hold | 10 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 35.7%
- Operating Margin
- 41.2%
- Gross Margin
- 61.4%
- Return on Equity (ROE)
- 95.0%
- Return on Assets (ROA)
- 21.3%
- Revenue Growth
- 11.5%
- Earnings Growth
- 11.8%
- Debt/Equity
- 105.40
- Current Ratio
- 3.03
- Beta
- 1.50
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 15, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| Jun 11, 2026 | Barclays | Overweight → Overweight |
| Jun 10, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| Jun 9, 2026 | UBS | Neutral → Neutral |
| May 1, 2026 | Citigroup | Buy → Buy |
| Apr 30, 2026 | Jefferies | Buy → Buy |